Clinical Trials Directory

Trials / Completed

CompletedNCT02355548

Outpatient Treatment of Low-risk Pulmonary Embolism

Rapid Risk Stratification for Outpatient Treatment of Low-risk Pulmonary Embolism

Status
Completed
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Intermountain Health Care, Inc. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is looking at the safety and effectiveness of treating Patients diagnosed with a low-risk Pulmonary Embolism (PE) in an outpatient setting instead of the standard, in-patient hospitalization. Patients have several medical tests done during their Emergency Department visit. Based on those tests, those who are determined to have a low-risk PE are eligible to participate in the study. Those choosing to participate are discharged after 12 hours of medical observation. Patients who choose to participate are followed up by telephone approximately 90 days later.

Conditions

Interventions

TypeNameDescription
OTHEROutpatient Treatment of Pulmonary EmbolismPatients who participate in the study will be treated for their pulmonary embolism in an outpatient setting instead of being hospitalized.

Timeline

Start date
2012-12-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2015-02-04
Last updated
2018-11-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02355548. Inclusion in this directory is not an endorsement.

Outpatient Treatment of Low-risk Pulmonary Embolism (NCT02355548) · Clinical Trials Directory